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Adenylylation of Rab proteins appears to be an intriguing mechanism that Legionella pneumophila uses to
modulate their activity during infection. Now the reverse reaction (deadenylylation) (Neunuebel et al., 2011;
Tan and Luo, 2011) and a new posttranslational modification (phosphocholination) of Rab1 (Mukherjee
et al., 2011) have been reported.There are a number of examples of bacte-
rial enzymes that covalently modify host
organism proteins for the strategic pur-
poses of the bacteria. Many of the modifi-
cations observed in earlier work are due to
bacterial toxins operating on GDP/GTP
(guanosine di-/triphosphate) binding pro-
teins, e.g., the adenosine diphosphate
(ADP) ribosylation and glycosylation of
Rho proteins (Aktories, 2011). In some
cases, these modifications are caused
by so-called effector proteins introduced
into host cells by the translocation/secre-
tion systems of intracellularly replicat-
ing bacteria. Recently, adenylylation (or
AMPylation; covalent transfer of an aden-
osine monophosphate [AMP] group to
an amino acid side chain) of host cell
Rho and Rab proteins was discovered
(Mu¨ller et al., 2010; Worby et al., 2009;
Yarbrough et al., 2009). VopS from
Vibrio parahaemolyticus and IbpA from
Histophilus somni are able to transfer
AMP to specific threonine or tyrosine
residues of switch I in RhoA, Rac, or
Cdc42, and DrrA/SidM from Legionella
pneumophila can transfer AMP to a tyro-
sine of switch II of Rab1. The modification
of proteins by the covalent addition of
an AMP group was first discovered more
than 40 years ago and is an important
mechanism for the regulation of the
activity of bacterial glutamine synthetases
(Stadtman, 2001), but until recently,
further examples were not found. The
new evidence suggests that the modifica-
tion is more widespread than previously
recognized. Two structurally divergent
domains have been identified with ad-
enylyl transferase (ATase) activity, one
of these being responsible for Rab1 ad-
enylylation by L. pneumophila and show-
ing a high structural homology to glu-
tamine synthetase adenylyl transferase
(GS-ATase) (Mu¨ller et al., 2010). Theother type of domain (FIC domain) was
first discovered as the Rho-adenylylating
activity in Vibrio parahaemolyticus VopS
(Yarbrough et al., 2009) and then in
Histophilus somni IbpA (Worby et al.,
2009). This domain has a conserved
sequence motif (HPFx[D/E]GN[G/K]R),
which has now been identified in 2700
cases, mainly in bacteria, but also in other
life forms, including humans in one case.
Adenylylation of GS, Rho, or Rab pro-
teins has a profound influence on their
activity. In the case of GS, the intrinsic
enzymatic activity is inhibited. Adenyly-
lated Rho proteins lose their ability to
interact with downstream partners, while
adenylylation of Rab1 negatively affects
its interaction with several types of inter-
action partners (Figure 1A). The biological
consequences of these modifications are
easy to understand in the case of GS, but
are complex and incompletely under-
stood in the case of GTPases of the Rho
and Rab families.
Two groups have now reported the
identification of a Legionella effector
protein (SidD)with deadenylylation activity
toward Rab1-AMP (Neunuebel et al.,
2011;TanandLuo,2011). Theapproaches
used were quite different, with one group
taking advantage of the observation that
DrrA/SidM is toxic when expressed in
eukaryotic cells, including yeast (Tan and
Luo, 2011). It was shown earlier that this
toxicity is linked to the protein’s adenylyla-
tion activity (Mu¨ller et al., 2010). Tan and
Luo introduced a L. pneumophila genomic
library into yeast harboring galactose-
inducible DrrA/SidM and were able to
obtain several clones in which the toxicity
of the latter was suppressed. All of these
clones included the gene coding for SidD
and further experiments in both yeast
and mammalian cells confirmed that
SidD was able to prevent the cytotoxicCell Host & Microbe 1effect of DrrA/SidM. Using recombinant
SidD, the authors demonstrated that the
protein was able to remove the AMP
group from Rab1-AMP. The predicted
secondary structure of SidD shows signif-
icant similarity with that of several pro-
tein phosphatases. Two acidic residues
in SidD, Asp92 and Asp110, align with
essential aspartate residues in these
phosphatases, and in keeping with this,
mutation of either to alanine led to loss of
deadenylylation activity and loss of the
ability of SidD toprotect yeast cells against
the toxic effects of DrrA/SidM.
The other group reporting the AMP
removal properties of SidD detected
this activity initially in extracts from
L. pneumophila (Neunuebel et al., 2011).
They noticed that the L. pneumophila
gene sidM is located next to sidD in the
bacterial genome, and it was this obser-
vation that prompted the Machner group
to test the possible activity of recombi-
nant SidD against Rab1-AMP. They could
easily demonstrate this activity, as well
as activity against Rab35, which is also
a substrate of the adenylylation reaction
of DrrA/SidM. Tan and Luo report that
several other Rabs (3, 4, 8, 1, 13, 14,
and 37) are weakly modified by DrrA/
SidM and are deadenylylated by SidD
(Tan and Luo, 2011).
The results reported in the two articles
on SidD lend support to the idea that
reversible adenylylation of Rab1 is a
mechanism to regulate its activity in a
controlled fashion. The exact purpose of
this, and indeed which cellular activities
are regulated, is still not completely
understood. After Rab1 is recruited to
Legionella-containing vacuoles (LCVs)
with the help of the GDP/GTP exchange
factor (GEF) activity of the multifunctional
protein DrrA/SidM, it is thought to coop-
erate with another Legionella effector,0, August 18, 2011 ª2011 Elsevier Inc. 89
Figure 1. Posttranslational Modifications of Rab1 by Legionella Effector Proteins
(A) Biochemical effects of Rab1 adenylylation and phosphocholination. The biochemical consequences of the modifications on the interaction with Rab1 binders
are depicted (blocked line/arrow, modification abolishes/does not abolish interaction with indicated molecules; amino acid numbering according to
human Rab1b).
(B) Order of events of Rab1 modification by Legionella effector proteins. DrrA recruits Rab1 to the LCV from Rab1:GDI complexes by exchanging GDP for GTP.
The ATase activity of DrrA generates adenylylated Rab1 that is mostly inaccessible by GAPs, thus keeping Rab1 in the GTP state. At later phases of infection,
SidD and LepB are released into the cytosol of the host cell. SidD hydrolytically liberates the AMP group from Rab1 and thereby renders it accessible to the
Legionella Rab1-GAP LepB, leading to LepB-stimulated GTP hydrolysis. The inactive Rab1 (Rab1:GDP) is subject to extraction and solubilization by GDI and
thus disappears from the LCV membrane. Alternatively, after recruitment by DrrA to the LCV, Rab1 can be phosphocholinated by AnkX. However, the molecular
consequences of Rab1 phosphocholination remain to be identified (CMP/CDP, cytidine mono-/diphosphate; AMP/ATP, adenosine mono-/triphosphate;
GDP/GTP, guanosine di-/triphosphate; PPi, pyrophosphate; Pi, phosphate; LCV, Legionella-containing vacuole; ATase, adenylyl transferase).
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the LCV (Machner and Isberg, 2006).
LidA has the properties of a Rab effector
molecule; i.e., it interacts preferentially
with the GTP-bound form of the GTPase,
in this case Rab1. The mechanism of the
vesicle recruitment process is unclear,
but is presumably related to the highly
complex mechanism of physiological
recruitment of ER-derived vesicles via
the ER-Golgi intermediate compartment
to the cis-Golgi, which is still not under-90 Cell Host & Microbe 10, August 18, 2011 ªstood in detail (see review by Sztul and
Lupashin, 2009). One parallel between
the two mechanisms appears to be that
activated Rab1 is present on both the
donor and acceptor membranes, with
that on the acceptor membrane (LCV)
being recruited by DrrA/SidM. However,
it is presently unclear why the adenylyla-
tion event occurs. It has been shown
that this leads to loss of the ability of
GTPase-activating proteins (GAPs), in-
cluding the Legionella effector LepB, to2011 Elsevier Inc.accelerate the hydrolysis of GTP by
Rab1 (Figure 1A). Rab1 could then be
considered to be permanently in the acti-
vated state, except that available evi-
dence suggests that its interaction with
effector molecules is inhibited (Mu¨ller
et al., 2010). The loss of GTPase ability
means that adenylylated Rab1 should be
effectively irreversibly bound to the LCVs
at this stage, since removal of Rabs from
membranes requires GTP hydrolysis to
GDP to allow extraction by the so-called
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Rab1 is removed from the membrane in
the course of the infection. The discovery
of the deadenylylase activity of SidD
offers a potential explanation of how this
can occur, with deadenylylation being
followed by LepB-stimulated GTP hydro-
lysis and extraction by GDI (Figure 1B).
In the report by the Machner group, it
was shown that DrrA/SidM appears in
the early phase of infection, followed by
SidD as DrrA/SidM is decaying, and then
LepB as SidD disappears. This supports
the sequence of events shown in Fig-
ure 1B, with DrrA/SidM localization of
Rab1 and GDP/GTP exchange preceding
its adenylylation, in keeping with the
observation that the GTP form of Rab1 is
the preferred substrate for adenylylation,
followed by deadenylylation by SidD and
GTP hydrolysis with the assistance of
LepB and Rab1 extraction by GDI.
In a further publication, Roy and
colleagues sought to demonstrate that
adenylylation of Rab1 actually occurs
during Legionella infection (Mukherjee
et al., 2011). Using a mass spectrometric
approach, they were indeed able to iden-
tify the adenylylated peptide (TITSSYYR)
expected from in vitro studies. Surpris-
ingly, this peptide was also present in a
different modified form, which was shown
to be due to the covalent addition of a
phosphocholine group to the serine pre-
ceding the tyrosine that is the site of addi-
tionof theAMPgroup. Incells infectedwith
a Legionella strain lacking DrrA/SidM
(Ddrra), Rab1 was not adenylylated but
was still phosphocholinated, showing
that DrrA/SidM is not responsible for the
new modification. In contrast, a strain
deficient in thegene for AnkX led to adeny-
lylation, but not phosphocholination, indi-
cating that AnkX, a protein known to
harbor a FIC motif, was needed for the
latter modification. In in vitro experiments
with recombinant AnkX, the authors
could show that AnkX uses cytidine di-
phosphate choline (CDP-choline) as a
substrate for the transferof aphosphocho-
line group to Rab1 (Figure 1A). In further
experiments, the already known pheno-
type induced by AnkX (Golgi disruption
and inhibition of alkaline phosphatase
secretion [Pan et al., 2008]) was shown
to be dependent on its phosphocholine
transferaseactivity, sinceanenzymatically
inactive variant with a histidine to ala-
nine exchange in the HPFx(D/E)GN(G/K)Rsequence motif (HPFRDANGR in the case
of AnkX) did not produce such a pheno-
type. Interestingly, mutation of the serine
toalanineat thesiteof phosphocholination
of Rab1 blocked alkaline phosphatase
secretion upon expression in HEK293
cells, suggesting an important role of the
residue in this process.
Neither adenylylation by DrrA/SidM nor
phosphocholination by AnkX are com-
pletely specific for Rab1, although this
appears to be the preferred substrate in
both cases (Mukherjee et al., 2011; Mu¨ller
et al., 2010). Interestingly, Rab35, which is
related to Rab1 and regarded as a
member of the Rab1 family, is a reason-
able substrate for both modifications.
As shown by the Roy group, Legionella
infection led to adenylylation and phos-
phocholination of Rab35 in a DrrA/SidM-
and AnkX-dependent manner, respec-
tively. In keeping with this, interference
with Rab35 function appears to occur
upon expression of AnkX, since there are
similar defects in endosome morphology
as when Rab35 function is disturbed by
other effects.
It was shown earlier that adenylylation
of Rab1 did not have a significant effect
on the interaction of the GTPase with the
GEF domain of DrrA/SidM. Due to lack of
availability of a cellular Rab1 GEF, the
effect on such an interaction has not
been reported. In the case of phospho-
cholination of Rab35, the ready availability
of its specific GEF, Connecdenn, allowed
the Roy group to demonstrate that the
interaction with this molecule is affected.
In contrast, phosphocholination of Rab1
appeared to have little effect on the inter-
action with the GEF domain of DrrA/SidM,
as in the case of adenylylation. Whether
this discrimination is of significance is
not clear, especially since it is highly likely
that adenylylation, at least, takes place
after nucleotide exchange catalyzed by
DrrA/SidM has occurred (Figure 1B).
At the level of enzymemechanisms, it is
of interest that FIC domains have now
been shown to catalyze distinct post-
translational modifications, despite their
likely conserved structures. The pro-
cesses discovered thus far include the
AMP- and phosphocholine-transfer reac-
tions discussed here. The substrates
share the property of being nucleotides,
and although the reaction is in both
cases transfer of a phosphate-containing
moiety, there are significant differences.Cell Host & Microbe 1In AMP transfer, the attack of the serine
or tyrosine hydroxyl group is on the
a-phosphate of adenosine triphosphate,
while in phosphocholine transfer it is the
b-phosphate which is attacked. Never-
theless, the similarities are obvious, and
the histidine in the HPFx(D/E)GN(G/K)R
(FIC domains) or HPFRDANGR (AnkX
FIC domain) sequence motif is essential
in both cases. It will be of interest to learn
more about the spectrum of reactions
catalyzed by the several thousand FIC
domains.
This intriguing list of discoveries on the
properties of Legionella effectors toward
Rab proteins raises the question of why
these mechanisms have been evolved
and retained in Legionella, especially
since several of the proteins involved are
not essential for infection. The rationaliza-
tion of this is that there is probably a high
degree of redundancy among the large
number of effectors. This then raises the
question of the identity of proteins that
can duplicate or emulate the effects of,
for example, DrrA/SidM. It seems likely
that many surprises will arise from further
detailed investigations of the interaction
between bacterial effectors and host cell
proteins.
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